The current valuation score of Werewolf Therapeutics Inc is 7.05, ranking 266 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.31, which is -8.18% below the recent high of -0.29 and -2309.96% above the recent low of -7.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.